Information
-
Trademark
-
98550094
-
International Classifications
- 5 - Pharmaceutical and veterinary preparations
- 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
- 40 - Treatment of materials
- 42 - Scientific and technological services and research and design relating thereto
- 44 - Medical services
-
Filing Date
May 14, 2024
4 months ago
-
Transaction Date
June 01, 2024
3 months ago
-
Status Date
May 14, 2024
4 months ago
-
Status Code
630
-
-
Attorney Docket Number
60895-595469
Attorney Name
Rebecca Liebowitz
-
Owners
Mark Drawing Code
4
Mark Identification
CLONALX
Case File Statements
- GS0401: Custom manufacture of therapeutic drugs, namely custom manufacture of cell therapies, cancer therapies, neoantigen-specific T cells, TCR-engineered T cells, cancer vaccines and neoantigen vaccines
- GS0091: Bioinformatics software; computer software platforms
- GS0051: Medical and veterinary preparations for therapeutic purposes; preparations for cancer therapy; antibodies; vaccines; personalised cancer vaccines; neoantigen vaccines; preparations for cell therapy; neoantigen-specific T cells; TCR-engineered T cells; preparations for modifying human or animal cells for medical or therapeutic purposes; preparations of blood extracted from humans or animals which have been adapted for medical or therapeutic purposes
- GS0441: Medical services; veterinary services; services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients; providing advice and consultancy in the field of medical and veterinary therapies; providing advice and consultancy in the field of cancer therapies and cancer vaccines
- GS0421: Scientific and technological services and research and design relating thereto; industrial analysis and research services; medical and veterinary research services including the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; scientific research in the development of new cancer therapies, including neoantigen-specific T cells and TCR-engineered T cells; scientific research in human and animal cell therapy; scientific research into vaccines, including personalised cancer vaccines and neoantigen vaccines; scientific research into preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services
Case File Event Statements
-
5/14/2024 - 4 months ago
1 - NEW APPLICATION ENTERED
Type: NWAP
